Logo image of ZUMZ

ZUMIEZ INC (ZUMZ) Stock Fundamental Analysis

NASDAQ:ZUMZ - Nasdaq - US9898171015 - Common Stock - Currency: USD

11.88  -0.32 (-2.62%)

After market: 11.88 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ZUMZ. ZUMZ was compared to 121 industry peers in the Specialty Retail industry. While ZUMZ has a great health rating, there are worries on its profitability. ZUMZ has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ZUMZ had negative earnings in the past year.
ZUMZ had a positive operating cash flow in the past year.
In multiple years ZUMZ reported negative net income over the last 5 years.
ZUMZ had a positive operating cash flow in 4 of the past 5 years.
ZUMZ Yearly Net Income VS EBIT VS OCF VS FCFZUMZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of ZUMZ (-0.27%) is comparable to the rest of the industry.
ZUMZ has a Return On Equity (-0.52%) which is comparable to the rest of the industry.
The Return On Invested Capital of ZUMZ (0.32%) is worse than 62.81% of its industry peers.
Industry RankSector Rank
ROA -0.27%
ROE -0.52%
ROIC 0.32%
ROA(3y)-2.3%
ROA(5y)2.92%
ROE(3y)-4.36%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
ZUMZ Yearly ROA, ROE, ROICZUMZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

Looking at the Operating Margin, with a value of 0.22%, ZUMZ is doing worse than 62.81% of the companies in the same industry.
ZUMZ's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 34.08%, ZUMZ perfoms like the industry average, outperforming 44.63% of the companies in the same industry.
ZUMZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.22%
PM (TTM) N/A
GM 34.08%
OM growth 3Y-69.24%
OM growth 5Y-45.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.98%
GM growth 5Y-0.75%
ZUMZ Yearly Profit, Operating, Gross MarginsZUMZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZUMZ is destroying value.
The number of shares outstanding for ZUMZ has been reduced compared to 1 year ago.
The number of shares outstanding for ZUMZ has been reduced compared to 5 years ago.
There is no outstanding debt for ZUMZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZUMZ Yearly Shares OutstandingZUMZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ZUMZ Yearly Total Debt VS Total AssetsZUMZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.51 indicates that ZUMZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZUMZ's Altman-Z score of 2.51 is fine compared to the rest of the industry. ZUMZ outperforms 61.16% of its industry peers.
ZUMZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.51
ROIC/WACC0.04
WACC9.18%
ZUMZ Yearly LT Debt VS Equity VS FCFZUMZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

ZUMZ has a Current Ratio of 2.07. This indicates that ZUMZ is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.07, ZUMZ belongs to the top of the industry, outperforming 83.47% of the companies in the same industry.
ZUMZ has a Quick Ratio of 1.13. This is a normal value and indicates that ZUMZ is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ZUMZ (1.13) is better than 77.69% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.13
ZUMZ Yearly Current Assets VS Current LiabilitesZUMZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

ZUMZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.15%, which is quite impressive.
ZUMZ shows a small growth in Revenue. In the last year, the Revenue has grown by 1.57%.
The Revenue has been decreasing by -2.97% on average over the past years.
EPS 1Y (TTM)98.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.09%
Revenue 1Y (TTM)1.57%
Revenue growth 3Y-9.1%
Revenue growth 5Y-2.97%
Sales Q2Q%-0.94%

3.2 Future

The Earnings Per Share is expected to grow by 173.06% on average over the next years. This is a very strong growth
ZUMZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.41% yearly.
EPS Next Y513.66%
EPS Next 2Y233.52%
EPS Next 3Y173.06%
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y1.34%
Revenue Next 3Y2.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZUMZ Yearly Revenue VS EstimatesZUMZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ZUMZ Yearly EPS VS EstimatesZUMZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

ZUMZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 47.87, the valuation of ZUMZ can be described as expensive.
ZUMZ's Price/Forward Earnings ratio is in line with the industry average.
ZUMZ is valuated expensively when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 47.87
ZUMZ Price Earnings VS Forward Price EarningsZUMZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

ZUMZ's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ZUMZ is cheaper than 99.17% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZUMZ is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 39.95
EV/EBITDA 0.43
ZUMZ Per share dataZUMZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZUMZ's earnings are expected to grow with 173.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y233.52%
EPS Next 3Y173.06%

0

5. Dividend

5.1 Amount

No dividends for ZUMZ!.
Industry RankSector Rank
Dividend Yield N/A

ZUMIEZ INC

NASDAQ:ZUMZ (4/25/2025, 8:00:02 PM)

After market: 11.88 0 (0%)

11.88

-0.32 (-2.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners82.05%
Inst Owner Change0%
Ins Owners20.72%
Ins Owner Change0.79%
Market Cap227.62M
Analysts47.5
Price Target18.36 (54.55%)
Short Float %6.25%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.44%
Min EPS beat(2)-4.41%
Max EPS beat(2)135.29%
EPS beat(4)3
Avg EPS beat(4)61.25%
Min EPS beat(4)-4.41%
Max EPS beat(4)135.29%
EPS beat(8)5
Avg EPS beat(8)-55.16%
EPS beat(12)7
Avg EPS beat(12)-42.07%
EPS beat(16)10
Avg EPS beat(16)130.42%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.57%
Max Revenue beat(2)-1.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.22%
Min Revenue beat(4)-2.57%
Max Revenue beat(4)2.03%
Revenue beat(8)4
Avg Revenue beat(8)-0.38%
Revenue beat(12)6
Avg Revenue beat(12)-0.36%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)-14.29%
PT rev (3m)-23.4%
EPS NQ rev (1m)-23.28%
EPS NQ rev (3m)-112.79%
EPS NY rev (1m)-68.06%
EPS NY rev (3m)-71.09%
Revenue NQ rev (1m)4.85%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 47.87
P/S 0.26
P/FCF 39.95
P/OCF 11
P/B 0.69
P/tB 0.76
EV/EBITDA 0.43
EPS(TTM)-0.06
EYN/A
EPS(NY)0.25
Fwd EY2.09%
FCF(TTM)0.3
FCFY2.5%
OCF(TTM)1.08
OCFY9.09%
SpS46.41
BVpS17.17
TBVpS15.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.52%
ROCE 0.41%
ROIC 0.32%
ROICexc 0.46%
ROICexgc 0.51%
OM 0.22%
PM (TTM) N/A
GM 34.08%
FCFM 0.64%
ROA(3y)-2.3%
ROA(5y)2.92%
ROE(3y)-4.36%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-71.81%
ROICexcg growth 5Y-43.58%
ROICexc growth 3Y-70.67%
ROICexc growth 5Y-42.87%
OM growth 3Y-69.24%
OM growth 5Y-45.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.98%
GM growth 5Y-0.75%
F-Score7
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 67.71%
Cap/Sales 1.69%
Interest Coverage 250
Cash Conversion 85.86%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 1.13
Altman-Z 2.51
F-Score7
WACC9.18%
ROIC/WACC0.04
Cap/Depr(3y)91.88%
Cap/Depr(5y)76.39%
Cap/Sales(3y)2.23%
Cap/Sales(5y)1.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.09%
EPS Next Y513.66%
EPS Next 2Y233.52%
EPS Next 3Y173.06%
EPS Next 5YN/A
Revenue 1Y (TTM)1.57%
Revenue growth 3Y-9.1%
Revenue growth 5Y-2.97%
Sales Q2Q%-0.94%
Revenue Next Year0.97%
Revenue Next 2Y1.34%
Revenue Next 3Y2.41%
Revenue Next 5YN/A
EBIT growth 1Y103.01%
EBIT growth 3Y-72.04%
EBIT growth 5Y-47.44%
EBIT Next Year6979.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y201.82%
FCF growth 3Y-63.72%
FCF growth 5Y-42%
OCF growth 1Y40.3%
OCF growth 3Y-46.48%
OCF growth 5Y-27.81%